文献速递头颈外科咽喉与嗓音

基因表达亚型预测人乳头瘤病毒阴性头颈癌淋巴结转移与生存

Gene Expression Subtype Predicts Nodal Metastasis and Survival in Human Papillomavirus-Negative Head and Neck Cancer.
PubMed 文献 · Laryngoscope · 2018-09-24

该回顾性队列与基因组分析基于TCGA头颈癌队列,将口腔鳞癌和喉鳞癌分为基底、间充质、非典型和经典型四种基因表达亚型。口腔鳞癌中间充质亚型与淋巴结转移风险升高相关,临床T1-2N0M0患者中间充质亚型可预测隐匿性淋巴结转移(相对风险=3.38,95%CI:1.08-10.69)。喉鳞癌中经典型亚型与总生存显著更差相关(风险比=4.32,95%CI:1.77-10.54,P=.001)。

要点

  • 口腔鳞癌间充质亚型与淋巴结转移风险升高相关。
  • 临床T1-2N0M0口腔鳞癌中间充质亚型可预测隐匿性淋巴结转移。
  • 喉鳞癌经典型亚型与总生存显著更差相关。

核心结论

  • 基因表达分析揭示了人乳头瘤病毒阴性头颈癌中潜在的淋巴结转移和生存新标志物。

研究设计与样本

  • 回顾性队列研究和基因组分析。
  • 从TCGA头颈癌队列中识别口腔鳞癌和喉鳞癌病例。
  • 使用RSEM从TCGA RNA-seq数据量化基因表达水平并将每个病例分配至四种亚型之一。

主要发现

  • 口腔鳞癌病例主要由间充质和基底亚型组成,喉鳞癌主要由经典型和非典型亚型组成。
  • 口腔鳞癌中间充质亚型与淋巴结转移风险升高显著相关。
  • 临床T1-2N0M0口腔鳞癌亚组分析显示间充质亚型可预测隐匿性淋巴结转移(相对风险=3.38,95%CI:1.08-10.69)。
  • 喉鳞癌中经典型亚型与总生存显著更差相关(风险比=4.32,95%CI:1.77-10.54,P=.001)。

关键数值与推荐

  • 口腔鳞癌临床T1-2N0M0患者中间充质亚型预测隐匿性淋巴结转移的相对风险=3.38(95%CI:1.08-10.69)。
  • 喉鳞癌经典型亚型与总生存更差相关的风险比=4.32(95%CI:1.77-10.54,P=.001)。

临床怎么用

  • 基因表达亚型可能辅助评估人乳头瘤病毒阴性口腔鳞癌和喉鳞癌的淋巴结转移风险与预后。
  • 未来研究将继续完善和验证这些标志物,以提供指导治疗的分子风险评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: Gene expression analyses of head and neck cancer have revealed four molecular subtypes: basal (BA), mesenchymal (MS), atypical (AT), and classical (CL). We evaluate whether gene expression subtypes in oral cavity squamous cell carcinoma (OCSCC) and laryngeal squamous cell carcinoma (LSCC) can be used to predict nodal metastasis and prognosticate survival. STUDY DESIGN: Retrospective cohort study and genomic analysis. METHODS: OCSCC and LSCC cases were identified from the The Cancer Genome Atlas (TCGA) head and neck cancer cohort. RNA-seq by expected maximization (RSEM) was used to quantify gene expression levels from TCGA RNA-seq data and to assign each case to one of four subtypes. Descriptive statistics were used to describe patient, disease, and treatment characteristics in each subtype. Cox regression and Kaplan-Meier analyses were used to determine associations with survival. RESULTS: OCSCC cases were comprised primarily of the MS and BA subtypes, whereas LSCC was comprised primarily of CL and AT subtypes. In OCSCC, the MS subtype was significantly associated with higher risk of nodal metastasis. In a subset analysis of clinically T1-2N0M0 OCSCC, we demonstrate that the MS subtype was predictive of occult nodal metastasis (relative risk = 3.38, 95% confidence interval [CI]: 1.08-10.69). In LSCC, the CL subtype was associated with significantly worse overall survival (hazard ratio = 4.32, 95% CI: 1.77-10.54, P = .001). CONCLUSIONS: Gene expression analysis reveals potential novel markers of nodal metastasis and survival in human papillomavirus-negative head and neck cancer. Future studies will continue to refine and validate these markers, with the goal of providing molecular risk assessments that guide therapy and improve patient outcomes. LEVEL OF EVIDENCE: 2b Laryngoscope, 129:154-161, 2019.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Zevallos JP, Mazul AL, Walter V, et al. Gene Expression Subtype Predicts Nodal Metastasis and Survival in Human Papillomavirus-Negative Head and Neck Cancer. Laryngoscope. 2018. PMID: 30247749. doi:10.1002/lary.27340

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。